Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Hofseth BioCare ASA's revenue per share for the
three
months ended in Jun. 2026 was $0.02.
Hofseth BioCare ASA's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.06.
Warning Sign:
Hofseth BioCare ASA revenue per share is in decline over the past 12 months.
During the past 12 months, the average Revenue Per Share Growth Rate of Hofseth BioCare ASA was -10.20% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was 24.80% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was 28.40% per year.
During the past 10 years, the average Revenue Per Share Growth Rate was 7.20% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Hofseth BioCare ASA's Revenue per Share or its related term are showing as below:
HOFBF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -45.4 Med: 17 Max: 420.5
Current: 24.8
During the past 13 years, Hofseth BioCare ASA's highest 3-Year average Revenue Per Share Growth Rate was 420.50% per year. The lowest was -45.40% per year. And the median was 17.00% per year.
HOFBF's 3-Year Revenue Growth Rate is ranked better than 89.27% of 1846
companies
in the Consumer Packaged Goods industry
Industry Median: 3.5
vs HOFBF: 24.80
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Hofseth BioCare ASA Revenue per Share Related Terms
Hofseth BioCare ASA Revenue per Share Historical Data
* Premium members only.
The historical data trend for Hofseth BioCare ASA's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HOFBF vs KHC, GIS, MKC: Revenue per Share Comparison
For the Packaged Foods subindustry, Hofseth BioCare ASA's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Hofseth BioCare ASA PS Ratio vs Consumer Packaged Goods Industry
For the Consumer Packaged Goods industry and Consumer Defensive sector, Hofseth BioCare ASA's PS Ratio distribution charts can be found below:
* The bar in red indicates where Hofseth BioCare ASA's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Hofseth BioCare ASA's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.06
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Hofseth BioCare ASA (HOFBF) has a Revenue per Share of $0.06 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Hofseth BioCare ASA and its competitors. According to the industry distribution chart, Hofseth BioCare ASA ranks #198 out of 1846 companies in the Consumer Packaged Goods industry, placing it in the top 10.7%.
Is Hofseth BioCare ASA's Revenue per Share too high?
Hofseth BioCare ASA's current Revenue per Share is $0.06. The Consumer Packaged Goods industry median Revenue per Share is 3.50. Hofseth BioCare ASA's value of $0.06 is 98.3% below this industry median. Based on the distribution chart, Hofseth BioCare ASA ranks #198 out of 1846 companies in the Consumer Packaged Goods industry, which is in the top quartile — a strong position relative to peers. Overall, Hofseth BioCare ASA has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does Hofseth BioCare ASA's Revenue per Share compare to KHC and GIS?
According to the Consumer Packaged Goods industry distribution chart, Hofseth BioCare ASA ranks #198 out of 1846 companies for Revenue per Share. This places Hofseth BioCare ASA in the top 11% of its industry — outperforming the majority of peers. The industry median Revenue per Share is 3.50. Hofseth BioCare ASA's value of $0.06 is 98.3% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Consumer Packaged Goods company?
The median Revenue per Share among Consumer Packaged Goods companies is 3.50, based on 1,846 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Hofseth BioCare ASA's current Revenue per Share of $0.06 is 98.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Hofseth BioCare ASA and its competitors. For the Consumer Packaged Goods industry, the median Revenue per Share is 3.50 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Hofseth BioCare ASA's current Revenue per Share is $0.06. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Hofseth BioCare ASA stock overvalued right now?
Hofseth BioCare ASA (HOFBF) has a current Revenue per Share of $0.06. The stock's GF Value™ is $0.23, compared to a current price of $0.17 — trading 27.6% below its estimated fair value. The current Revenue per Share is $0.06 and 98.3% below the Consumer Packaged Goods industry median of 3.50. Hofseth BioCare ASA's overall GF Score™ is 60/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Hofseth BioCare ASA (HOFBF), the current Revenue per Share is $0.06 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Hofseth BioCare ASA (HOFBF) Overvalued in 2026?
Based on GuruFocus' analysis, Hofseth BioCare ASA stock appears to be undervalued.
The current stock price of $0.17 is trading 27.6% below its estimated GF Value™ of $0.23.
Key valuation signals for HOFBF:
Revenue per Share: $0.06
GF Value™: $0.23 vs. price of $0.17 (27.6% below fair value)
Industry Position: 98.3% below the Consumer Packaged Goods median (#198 of 1846)
No single metric tells the full story. See the HOFBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Hofseth BioCare ASA is a Norway-based company engaged in the business of developing, manufacturing, marketing, and selling marine ingredients such as oil, calcium, and protein products. Its brands, which also generate revenue, include salmon oil (OmeGo), water-soluble protein (ProGo), calcium/collagen (CalGo and NT-II), and non-soluble protein (PetGo), all of which are produced in the Midsund plant. The firm sells its products to various segments of the human nutrition market, such as sports nutrition, supplements, and health foods, as well as to the market within nutrition for the pet and feed industry. Geographically, the company generates maximum revenue from Europe, followed by North America and Asia.
60GF Score
Get the complete analysis for HOFBF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HOFBF has been successfully added to your 
